Table 3. The different release scenarios modeled and the corresponding figures that summarize the simulation results; when a fitness cost was associated with the anti-pathogen gene, we assumed that this reduced survivorship during the egg stage by 5% per copy of the gene (M = male-only releases, MF = releases of males and females or containers containing tetracycline, for egg releases).
Fitness cost | Life stage | Homogenous releases | Point-source (regular) releases | Point-source (random) releases | Corresponding figures summarizing results |
Present | Adult | M, MF | M, MF | – | 4, 5, S3 |
Present | Egg | – | M, MF | M, MF | 6 |
Absent | Adult | M, MF | M, MF | – | 4, 5, S3 |
Absent | Egg | – | M, MF | M, MF | 7 |